APREC – Alliance Pour la Recherche En Cancérologie

Our expertise

Substantial projects carried out against cancer

The work carried out by APREC has allowed and continues to allow significant progress every day:

  1. In the treatment of many cancers: breast cancer, ovarian cancer, prostate cancer, lung cancer, digestive cancers, sarcomas,…
  2. In mastering exceptional technologies. Thus the intensification of chemotherapy followed by auto-transplantation of haematopoietic stem cells makes it possible to save young patients suffering from testicular cancer or germ cell tumor resistant to traditional treatments. The APREC team is one of the first in the world in the mastery and implementation of these treatments

Our flagship program

Our APREC 389 program is a “transfer” research that aims to restore the effectiveness of immune cells paralyzed by cancer, using a totally original approach compared to all existing “immunotherapies”. The experimental results obtained to this date are already extremely promising.

OUR MEDICAL SKILLS

HIGH DOSE CHEMOTHERAPY WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

JEAN-PIERRE LOTZ, MD, PHD

BREAST CANCER

DR. JOSEPH GLIGOROV

GYNECOLOGICAL CANCERS

DR. FRÉDÉRIC SELLE

LUNG CANCER

PR. JACQUES CADRANEL

DIGESTIVE TRACT CANCERS

PR. THIERRY ANDRÉ

PROSTATE CANCER

PR. PHILIPPE SEBE

ONCOGERIATRICS

DR. DANIELE AVENIN